H-2L-restricted recognition of viral antigens In the H-2d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L
- PMID: 6286837
- PMCID: PMC2186797
- DOI: 10.1084/jem.156.3.778
H-2L-restricted recognition of viral antigens In the H-2d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L
Abstract
H-2d-encoded gene products were analyzed as restriction antigens for anti-vesicular stomatitis virus (VSV) cytotoxic T lymphocytes (CTL). Cold target competition experiments revealed that VSV recognition was H-2D region-restricted; H-2K-end-restricted recognition of VSV could not be demonstrated. That VSV is not recognized in the context of K-region-encoded gene products is also supported by the observation that H-2dm1 and H-2dm2 mice, strains that contain H-2Kd but have an alteration in H-2L and/or H-2D/L, are nonresponders in the CTL assay. Two different lines of evidence eliminated H-2Dd, H-2Md, and H-2Rd as the restriction antigens: (a) H-2dm2-VSV inhibitors that express H-2Dd and H-2Md did not block the lysis of P815-VSV targets by Balb/c anti-VSV killer cells, and (b) a hybridoma specific for H-2Dd failed to inhibit killer cell activity in this same effector/target combination. However, two monoclonal antibodies specific for H-2Ld but not H-2Rd completely blocked anti-VSV cytotoxic activity. Taken together, in the H-2d haplotype, anti-VSV CTL recognize VSV solely in the context of the H-2Ld molecule. This is the first demonstration of the exclusive use by a mouse stain of the H-2L molecule only for H-2-restricted recognition, and thus supports the notion that H-2L plays a major role in restricting antigen specific recognition. Finally, the fact that an anti-H-2Ld monoclone completely blocked an H-2dm2 anti-BALB/c CTL response indicates that H-2R, a molecule absent in H-2dm2 anti-BALB/c CTL response indicates that H-2R, a molecule absent in H-2dm2 but not BALB/c, does not sensitize H-2 alloreactive CTL.
Similar articles
-
Cell membrane antigens recognized by anti-viral and anti-trinitrophenyl cytotoxic T lymphocytes.Immunol Rev. 1981;58:73-94. doi: 10.1111/j.1600-065x.1981.tb00350.x. Immunol Rev. 1981. PMID: 6273294 Review. No abstract available.
-
Use of DNA-mediated gene transfer to analyze the role of H-2Ld in controlling the specificity of anti-vesicular stomatitis virus cytotoxic T cells.J Exp Med. 1983 Apr 1;157(4):1261-72. doi: 10.1084/jem.157.4.1261. J Exp Med. 1983. PMID: 6187888 Free PMC article.
-
Molecular heterogeneity of H-2 antigens.Immunol Rev. 1981;60:5-22. doi: 10.1111/j.1600-065x.1981.tb00360.x. Immunol Rev. 1981. PMID: 6171504 Review.
-
Possible mechanisms by which the H-2Kbm3 mutation may decrease cytotoxic T-lymphocyte recognition of vesicular stomatitis virus nucleoprotein antigen.J Virol. 1987 Jun;61(6):1992-8. doi: 10.1128/JVI.61.6.1992-1998.1987. J Virol. 1987. PMID: 3033326 Free PMC article.
-
Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.J Immunol. 1990 Aug 1;145(3):985-94. J Immunol. 1990. PMID: 1695651
Cited by
-
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma.Immunology. 2015 Sep;146(1):33-49. doi: 10.1111/imm.12477. Epub 2015 Jun 15. Immunology. 2015. PMID: 25959091 Free PMC article.
-
Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes.Infect Immun. 2002 Aug;70(8):4009-18. doi: 10.1128/IAI.70.8.4009-4018.2002. Infect Immun. 2002. PMID: 12117906 Free PMC article.
-
Antigen processing of vesicular stomatitis virus in situ. Interdigitating dendritic cells present viral antigens independent of marginal dendritic cells but fail to prime CD4(+) and CD8(+) T cells.Immunology. 2000 Dec;101(4):512-20. doi: 10.1046/j.1365-2567.2000.t01-1-00137.x. Immunology. 2000. PMID: 11122455 Free PMC article.
-
Control of cytomegalovirus in bone marrow transplantation chimeras lacking the prevailing antigen-presenting molecule in recipient tissues rests primarily on recipient-derived CD8 T cells.J Virol. 1998 Oct;72(10):7733-44. doi: 10.1128/JVI.72.10.7733-7744.1998. J Virol. 1998. PMID: 9733809 Free PMC article.
-
The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide.Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6880-5. doi: 10.1073/pnas.94.13.6880. Proc Natl Acad Sci U S A. 1997. PMID: 9192660 Free PMC article.